Xue-Qi Liu

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Endoplasmic Reticulum Stress

Signaling Pathway

Diabetic Nephropathy

Top Venues

Drug design, development and therapy

Oxidative medicine and cellular longevity

Diabetes, metabolic syndrome and obesity : targets and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Xian Wang, Han-Xu Zeng, Ling Jiang, Xue-Qi Liu, Yue-Bo Huang, Yong-Gui Wu
Clinical Significance of Glomerular Autophagy in Evaluation of Diabetic Kidney Disease Progression. Diabetes, metabolic syndrome and obesity : targets and therapy 15 (2022)
Yue-Bo Huang, Ling Jiang, Xue-Qi Liu, Xian Wang, Li Gao, Han-Xu Zeng, Wei Zhu, Xue-Ru Hu, Yong-Gui Wu
Melatonin Alleviates Acute Kidney Injury by Inhibiting NRF2/Slc7a11 Axis-Mediated Ferroptosis. Oxidative medicine and cellular longevity 2022 (2022)
Lei Lei, Jing Zhao, Xue-Qi Liu, Juan Chen, Xiang-Ming Qi, Ling-Ling Xia, Yong-Gui Wu
Wogonin Alleviates Kidney Tubular Epithelial Injury in Diabetic Nephropathy by Inhibiting PI3K/Akt/NF-κB Signaling Pathways. Drug design, development and therapy 15 (2021)
Zhi-Chao Zheng, Wei Zhu, Lei Lei, Xue-Qi Liu, Yong-Gui Wu
Wogonin Ameliorates Renal Inflammation and Fibrosis by Inhibiting NF-κB and TGF-β1/Smad3 Signaling Pathways in Diabetic Nephropathy. Drug design, development and therapy 14 (2020)